All News Amplia Therapeutics Limited

Equities

ATX

AU0000023822

Market Closed - Australian S.E. Other stock markets 02:10:24 2024-07-12 am EDT			5-day change	1st Jan Change
0.062 ^AUD	+3.33%		+1.64%	-22.50%

Jul. 03	Amplia Therapeutics Completes Enrollment for Phase 2A Pancreatic Cancer Trial; Shares Up 3%	MT
May. 30	Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Amplia Therapeutics Completes Enrollment for Phase 2A Pancreatic Cancer Trial; Shares Up 3%	Jul. 02	MT
Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 30	CI
Amplia Therapeutics Completes AU$4.27 Million Entitlement Offer; Shares Up 9%	May. 14	MT
Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing	Apr. 16	MT
Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II	Mar. 27	MT
Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3%	Mar. 26	MT
Amplia Therapeutics moves to next phase of pancreatic cancer treatment trial	Feb. 13	AQ
Amplia Therapeutics Secures US FDA Clearance for Proposed Pancreatic Cancer Trial	Jan. 17	MT
Amplia Therapeutics Limited Announces FDA Clearance of it's IND for Pancreatic Cancer Trial in US	Jan. 17	CI
Amplia Therapeutics Doses First Patient in Phase 2A Pancreatic Cancer Trial	Jan. 16	MT
Amplia Therapeutics Secures South Korean Regulatory Approval for Pancreatic Cancer Trial; Shares Up 3%	Dec. 04	MT
Amplia Therapeutics Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 20	CI
Amplia Therapeutics Receives AU$2.4 Million R&D Tax Rebate	23-10-18	MT
Amplia Therapeutics Appoints CFO	23-09-25	MT
Amplia Therapeutics Limited Announces Chief Financial Officer Changes	23-09-24	CI
Amplia Therapeutics Gets Nod to Name Drug AMP945 Narmafotinib	23-06-23	MT
Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt	23-05-29	CI
Amplia secures funding to assess AMP945 topical applications	23-05-22	AQ
Amplia Therapeutics to Enter Research Collaboration with CSIRO; Shares Rise 7%	23-05-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Amplia Therapeutics Limited

Equities

ATX

AU0000023822

All News

Filters